Диссертация (1174301), страница 27
Текст из файла (страница 27)
– 2005. –47(1). – P. 32-40.Honma, N.et al. Differences in clinical importance of Bcl-2 in breast canceraccording to hormone receptors status or adjuvant endocrine therapy // BMCCancer. – 2015. – 15(1). – P. 698.Hornick J. L., O.R.D., Polyps of the large intestine, in Surgical pathology of thegastrointestinal tract, liver, biliary tract and pancreas, / G.J.R. Odze R. D., Editor.– 2015.
–Elsevier. –.Janjua, H.G., Hogdall E., and Linnemann D. Hyperplastic polyps of the colon andrectum - reclassification, BRAF and KRAS status in index polyps and subsequentcolorectal carcinoma // Apmis. – 2015. – 123(4). – P. 298-304.Jass, J.R. Relation between metaplastic polyp and carcinoma of the colorectum //The Lancet. – 1983. – 321(8314). – P. 28-30.Jass, J.R. Hyperplastic polyps and colorectal cancer: is there a link? // ClinGastroenterol Hepatol. – 2004. – 2(1). – P. 1-8.Jass, J.R.et al.
Advanced colorectal polyps with the molecular and morphologicalfeatures of serrated polyps and adenomas: concept of a 'fusion' pathway tocolorectal cancer // Histopathology. – 2006. – 49(2). – P. 121-31.24091.92.93.94.95.96.97.98.99.100.101.102.103.104.105.Jensen, P.et al. Observer variability in the assessment of type and dysplasia ofcolorectal adenomas, analyzed using kappa statistics // Dis Colon Rectum. –1995.
– 38(2). – P. 195-8.Jiao, Y.F.et al. Serrated adenoma of the colorectum undergoes a proliferationversus differentiation process: new conceptual interpretation of morphogenesis //Oncology. – 2008. – 74(3-4). – P. 127-34.Johannsen, L.G., Momsen O., and Jacobsen N.O. Polyps of the large intestine inAarhus, Denmark. An autopsy study // Scand J Gastroenterol. – 1989.
– 24(7). –P. 799-806.Joo, M., Shahsafaei A., and Odze R.D. Paneth cell differentiation in colonicepithelial neoplasms: evidence for the role of the Apc/beta-catenin/Tcf pathway //Hum Pathol. – 2009. – 40(6). – P. 872-80.Jung, J.H.et al. [Immunohistochemical expression of p53, Bcl-2, and Ki-67proteins in traditional serrated adenomas of colon] // Korean J Gastroenterol. –2013.
– 62(6). – P. 336-43.Juniku-Shkololli, A.et al. Expression of Immunohistochemical Markers ofProgression in Pre-cancerous and Cancerous Human Colon: Correlation withSerum Vitamin D Levels // Anticancer Res. – 2015. – 35(3). – P. 1513-20.Kaklamanis, L.et al. p53 expression in colorectal adenomas // The AmericanJournal of Pathology. – 1993.
– 142(1). – P. 87-93.Kaklamanis, L., Savage, A., Mortensen, N., Tsiotos, P., DoussisAnagnostopoulou, I., Biddolph, S., Whitehouse, R., Harris, A. L., Gatter, K. C.Early expression of bcl-2 protein in the adenoma-carcinoma sequence ofcolorectal neoplasia // J Pathol. – 1996. – 179(1). – P. 10-4.Kang, M.et al. Ki-67, p53, and Bcl-2 expression of serrated adenomas of thecolon // Am J Surg Pathol.
– 1997. – 21(4). – P. 417-23.Kawasaki, K.et al. Colonoscopic features and malignant potential of sessileserrated adenomas: comparison with other serrated lesions and conventionaladenomas // Colorectal Dis. – 2016. – 18(8). – P. 795-802.Khalid, O.et al. Reinterpretation of histology of proximal colon polyps calledhyperplastic in 2001 // World J Gastroenterol. – 2009. – 15(30). – P. 3767-70.Kim, J.-H.et al. Implications of Bcl-2 and its interplay with other molecules andsignaling pathways in prostate cancer progression // Expert Opinion onTherapeutic Targets. – 2017. – 21(9). – P. 911-920.Kim, J.H.et al. Gastric-type expression signature in serrated pathway-associatedcolorectal tumors // Hum Pathol.
– 2015. – 46(5). – P. 643-56.Kim, J.H.et al. Loss of CDX2/CK20 expression is associated with poorlydifferentiated carcinoma, the CpG island methylator phenotype, and adverseprognosis in microsatellite-unstable colorectal cancer // Am J Surg Pathol. –2013. – 37(10). – P.
1532-41.Kim, K.M.et al. KRAS mutations in traditional serrated adenomas from Koreaherald an aggressive phenotype // Am J Surg Pathol. – 2010. – 34(5). – P. 667-75.241106. Kim, M.J.et al. The significance of ectopic crypt formation in the differentialdiagnosis of colorectal polyps // Diagn Pathol. – 2014.
– 9. – P. 212.107. Kim, M.J.et al. Traditional serrated adenoma of the colorectum: clinicopathologicimplications and endoscopic findings of the precursor lesions // Am J Clin Pathol.– 2013. – 140(6). – P. 898-911.108. Klein, J.L.et al. Distribution, size and shape of colorectal adenomas asdetermined by a colonoscopist with a high lesion detection rate: Influence of age,sex and colonoscopy indication // United European Gastroenterol J. – 2016. –4(3). – P. 438-48.109.
Konishi, F. and Morson B.C. Pathology of colorectal adenomas: a colonoscopicsurvey // J Clin Pathol. – 1982. – 35(8). – P. 830-41.110. Koornstra J. J., J.S.d., Hollema H., Vries E. G. E. de, J.H. Kleibeuker. Changes inapoptosis during the development of colorectal cancer: a systematic review of theliterature // Critical Reviews in Oncology/Hematology.
– 2003. – 45. – P. 37-53.111. Kudo, S.et al. Nonpolypoid neoplastic lesions of the colorectal mucosa //Gastrointest Endosc. – 2008. – 68(4 Suppl). – P. S3-47.112. Lash, R.H., Genta R.M., and Schuler C.M. Sessile serrated adenomas: prevalenceof dysplasia and carcinoma in 2139 patients // J Clin Pathol. – 2010. – 63(8). – P.681-6.113. Lazarus, R.et al. The risk of metachronous neoplasia in patients with serratedadenoma // Am J Clin Pathol.
– 2005. – 123(3). – P. 349-59.114. Li L., F.X., Zhang W., Xiao L., Qiu Y., Peng Y., Shi L., Chen X., Zhou X., DengM. Wnt signaling pathway is activated in right colon serrated polyps correlatingto specific molecular form of β-catenin. // Hum Pathol. – 2013. – 44(6). – P.1079-88.115. Li, M.K.
and Folpe A.L. CDX-2, a new marker for adenocarcinoma ofgastrointestinal origin // Adv Anat Pathol. – 2004. – 11(2). – P. 101-5.116. Li, Q. and Lozano G. Molecular pathways: targeting Mdm2 and Mdm4 in cancertherapy // Clin Cancer Res. – 2013.
– 19(1). – P. 34-41.117. Li, X.L.et al. P53 mutations in colorectal cancer - molecular pathogenesis andpharmacological reactivation // World J Gastroenterol. – 2015. – 21(1). – P. 8493.118. Lieberman, D.A.et al. Guidelines for colonoscopy surveillance after screeningand polypectomy: a consensus update by the US Multi-Society Task Force onColorectal Cancer // Gastroenterology. – 2012. – 143(3).
– P. 844-57.119. Lindner, A.U.et al. Systems Analysis of BCL2 Protein Family InteractionsEstablishes a Model to Predict Responses to Chemotherapy // Cancer Research. –2013. – 73(2). – P. 519-528.120. Liu, X.et al. CDX2 serves as a Wnt signaling inhibitor and is frequentlymethylated in lung cancer // Cancer Biol Ther. – 2012. – 13(12). – P. 1152-7.121. Loeve, F.et al.
Colorectal cancer risk in adenoma patients: a nation-wide study //Int J Cancer. – 2004. – 111(1). – P. 147-51.242122. Longacre, T.A. and Fenoglio-Preiser C.M. Mixed hyperplastic adenomatouspolyps/serrated adenomas. A distinct form of colorectal neoplasia // Am J SurgPathol. – 1990. – 14(6). – P. 524-37.123. Lu, Z.R., Jayasurya, Phillip. Synchronous sessile serrated adenoma and gobletcell carcinoid in the appendix: A case report and literature review // Pathology. –2015.
– 48. – P. S75.124. MacDonald B. T., T.K., He X. Wnt/β-catenin signaling: components,mechanisms, and diseases // Developmental Cell. – 2009. – 17(1). – P. 9-26.125. Mahajan, D.et al. Reproducibility of the villous component and high-gradedysplasia in colorectal adenomas <1 cm: implications for endoscopic surveillance// Am J Surg Pathol. – 2013.
– 37(3). – P. 427-33.126. Martinez, M.E.et al. A pooled analysis of advanced colorectal neoplasiadiagnoses after colonoscopic polypectomy // Gastroenterology. – 2009. – 136(3).– P. 832-41.127. Menezes, H.L.et al. Analysis of the immunohistochemical expressions of p53,bcl-2 and Ki-67 in colorectal adenocarcinoma and their correlations with theprognostic factors // Arq Gastroenterol. – 2010. – 47(2).
– P. 141-7.128. Mochizuka, A.et al. Hyperplastic polyps and sessile serrated 'adenomas' of thecolon and rectum display gastric pyloric differentiation // Histochem Cell Biol. –2007. – 128(5). – P. 445-55.129. Mohammadi, M.et al. Sessile serrated lesion and its borderline variant - Variableswith impact on recorded data // Pathol Res Pract.
– 2011. – 207(7). – P. 410-6.130. Murakami T., M.H., Saito T., Takahashi M., Sakamoto N., Fukui N., Yao T.,Watanabe S. Distinct WNT/β-catenin signaling activation in the serratedneoplasia pathway and the adenoma-carcinoma sequence of the colorectum //Mod Pathol. – 2015. – 28(1). – P. 146-58.131. Muto, T., Bussey H.J., and Morson B.C.
The evolution of cancer of the colon andrectum // Cancer. – 1975. – 36(6). – P. 2251-70.132. Nakazawa K., N.D., Yoshid K. Tumor suppressor p53 induces miR-1915processing to inhibit Bcl-2 in the apoptotic response to DNA damage // TheFEBS Journal. – 2014. – 281(13). – P. 2937-44.133. Ngo, N.T.et al. Differential expression of p53 and p504s in hyperplastic polyp,sessile serrated adenoma and traditional serrated adenoma // Int J Colorectal Dis.– 2010. – 25(10).
![](https://s.studizba.com/z.php?f=/templates/si/i/noavatar.png&w=100&h=100&t=1"){kind=avatar}
